AskBio buys BrainVectis for early-stage gene therapies
AskBio acquires gene therapy biotech working on treatments for neurodegenerative disorders.
AskBio acquires gene therapy biotech working on treatments for neurodegenerative disorders.
Takeda in global licensing agreement with ProThera to develop plasma-based therapies for inflammatory conditions.
J&J agrees a manufacturing partnership with Emergent, as it looks to hit its target of one billion doses.